Miguel Forte

Company: Kiji Therapeutics

Job title: Chief Executive Officer

Seminars:

Panel Discussion: Driving Industry Collaborations to Unlock New Therapeutic Opportunities 8:30 am

Evaluating public and private partnerships between pharma and biotech companies institutions Discussing ideal criteria for company collaborations and investment to improve discovery efficiency Highlighting key strategies from successful collaborations to direct and refine future collaborative effortsRead more

day: Day Two AM

Roundtable Discussion: Exploring Strategies for Treg Tracking & Persistence Analysis 11:00 am

Discussing tracking techniques to aid in identifying Treg migration and longevity Identifying opportunities for strategic optimization Identifying effective Treg persistence and functionality biomarkers to enhance persistence analysisRead more

day: Focus Day

Roundtable Discussion: Reflecting Upon Key Obstacles in Preclinical Treg Research & Discovery 11:45 am

Exploring difficulties in effectively utilizing preclinical models in research Addressing phenotypic uncertainties when identifying and characterizing Tregs to enhance accurate identification Understanding Treg Plasticity between regulatory and inflammatory phenotypes to prevent the change of Tregs to T effector cells Considering the specificity and selectivity limitations of Tregs therapiesRead more

day: Focus Day